Company Filing History:
Years Active: 2001
Title: Scott Higgins: Innovator in Genetic Diagnostics
Introduction
Scott Higgins is a notable inventor based in Paisley, GB. He has made significant contributions to the field of genetic diagnostics through his innovative work. His expertise lies in the detection and identification of genetic mutations, which has important implications for medical science.
Latest Patents
Scott Higgins holds a patent for "Diagnostics based on mass spectrometric detection of translated target polypeptides." This invention provides a means of detecting and identifying mutations in a genetic region. It also quantifies the number of repeat units in a trinucleotide repeat by transcription and translation of the genetic region into a target polypeptide. The method does not require radioisotopic or fluorescent labeling of the target polypeptide. The invention is based on mass spectrometric determination of the mass of the encoded target polypeptide. It allows for comparison of the mass of the polypeptide with its expected mass or with the mass of a polypeptide of known identity. This innovative approach can be used to diagnose genetic diseases, chromosomal abnormalities, predispositions to diseases, infections by pathogenic organisms, or for determining identity or heredity.
Career Highlights
Scott Higgins is currently associated with Sequenom, Inc., where he continues to advance his research in genetic diagnostics. His work has garnered attention for its potential to improve diagnostic accuracy and patient outcomes in genetic testing.
Collaborations
Some of his notable coworkers include Daniel P Little and Hubert Köster. Their collaborative efforts contribute to the innovative environment at Sequenom, Inc.
Conclusion
Scott Higgins is a pioneering inventor whose work in genetic diagnostics has the potential to transform the field. His patent reflects a significant advancement in the detection of genetic mutations, showcasing his commitment to innovation in medical science.